VISX Message Board - Msg: 3720772

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vector1 who wrote (453)	3/15/1998 11:08:00 PM
From: pappy	Read Replies (1) of 1754

Zacks Investment Research, Inc. -Company Reports- VISX INC DEL Ticker Exchange Industry Type VISX NSDQ LASERS-SYS/COMP Small Shares/ Outstanding 15.4 MM Institutions 57.38% Insiders 5.83% VISX, INC. is engaged in the design and development of proprietary technologies and systems for laser vision correction (""LVC""), an outpatient surgical procedure to treat refractive vision disorders such as nearsightedness, astigmatism and farsightedness with the goal of eliminating or reducing reliance on eyeglasses and contact lenses. In LVC, a computer-controlled excimer laser ablates, or removes, submicron layers of tissue from the surface of the cornea to reshape the eye, thereby improving visual acuity. Rec Price: $ 28.25 P/E: 24.8 Mkt Cap: $436 MM Div Rate: $ 0.00 Yield: $ 0.0 Sales (12Mo): $ 69 MM Slsr: 36% EPS: 219% Div G: Zacks Rank: Sell

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next